A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer
Clinical trial NCT02030678 · UNKNOWN
Trial details
- NCT number
- NCT02030678
- Sponsor
- Liaoning Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2019-12-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.